Finance

Lists
KRMD:NASDAQ
KORU Medical Systems Inc
USD 2,96
-1,33%
(-0,040) 1D
USD 2,96
0,00% (0,00)
After hours
Closed: 9 Okt., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KRMD...
Open
USD 2,99
High
USD 3,07
Low
USD 2,94
Mkt. cap
136,67 m
Avg. vol.
246,60 k
Volume
202,58 k
52-wk high
USD 6,61
52-wk low
USD 2,86
EPS
-USD 0,04
Beta
0,39
Shares outstanding
46,17 m
No. of employees
73
Open
USD 2,99
High
USD 3,07
Low
USD 2,94
Mkt. cap
136,67 m
Avg. vol.
246,60 k
Volume
202,58 k
52-wk high
USD 6,61
52-wk low
USD 2,86
EPS
-USD 0,04
Beta
0,39
Shares outstanding
46,17 m
No. of employees
73
News stories
From web sources and news partners
About KORU Medical Systems Inc
CEO-
Employees73
Founded1980
HeadquartersMahwah, New Jersey, Verenigde State van Amerika
SectorMedical device
Analyst ratings
Based on 5 analysts giving stock ratings to KRMD in the past 3 months
Strong buy
Buy
4
Hold
1
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for KRMD in the last 3 months.
Highest
Current USD 2,96
USD 8,00 (+170,27%)
Average
USD 6,60 (+122,97%)
Lowest
USD 5,00 (+68,92%)
Analyst
Recommendation
Action
Price target
Projected
Date
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
USD 6,00
+102,7%
08/12/2026
Unknown Analyst
B. Riley Securities
Buy
Reiterated
USD 8,00
+170,3%
08/07/2026
Chase Knickerbocker
Craig-Hallum
Buy
Reiterated
USD 6,00
+102,7%
08/06/2026
Jason Bednar
Piper Sandler
Hold
Reiterated
USD 5,00
+68,9%
08/06/2026
Frank Takkinen
Lake Street
Buy
Reiterated
USD 8,00
+170,3%
08/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
10,40 m
10,90 m
11,76 m
12,05 m
Cost of goods sold
4,14 m
4,08 m
4,53 m
4,20 m
Cost of revenue
4,14 m
4,08 m
4,53 m
4,20 m
Research and development expenses
933,11 k
1,14 m
1,32 m
1,07 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,99 m
6,04 m
6,58 m
5,94 m
Operating expense
7,13 m
7,36 m
8,10 m
7,22 m
Total operating expenses
11,27 m
11,44 m
12,63 m
11,42 m
Operating income
-867,68 k
-547,10 k
-864,92 k
626,99 k
Other non operating income
3,21 k
6,70 k
-
-
EBT including unusual items
-778,12 k
-482,17 k
-807,08 k
258,25 k
EBT excluding unusual items
-778,12 k
-482,17 k
-807,08 k
664,52 k
Income tax expense
-150,00
4,68 k
-
5,80 k
Effective tax rate
0,02%
-0,97%
-
2,25%
Other operating expenses
-
-
-
-
Net income
-777,97 k
-486,86 k
-807,08 k
252,45 k
Net profit margin
-7,48%
-4,47%
-6,86%
2,10%
Earnings per share
-
0,01
-
0,02
Interest and investment income
74,57 k
66,70 k
81,00 k
59,87 k
Interest expense
-
-
-
-
Net interest expenses
74,57 k
66,70 k
81,00 k
59,87 k
Depreciation and amortization charges
204,48 k
179,17 k
197,53 k
210,03 k
EBITDA
-663,20 k
-485,83 k
-667,39 k
837,02 k
Gain or loss from assets sale
-
-6,70 k
-
406,27 k
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google-programme